Prevention of complications of subcutaneous peritoneal access devices in intraperitoneal chemotherapy of ovarian carcinoma.
The experience from 133 patients with ovarian cancer treated with intraperitoneal chemotherapy are reported. Type of PAC, the patient suitable for IP chemotherapy, the surgeon and the implantation technique and the timing are discussed with special attention to avoid complications in these patients.
Malmström
H
H
Department of Gynecologic Oncology, University Hospital, Linköping, Sweden.
D004343:Drug Implants / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000295:instrumentation* / Q000379:methods; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D004343:Drug Implants